Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker

Weight loss and hypophagia after high-dose AT1-blockade is only observed after high dosing and depends on regular leptin signalling but not blood pressure

(2011) Helge Müller-Fielitz et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway

(2010) Xiaoli Feng et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Potentiation by candesartan of protective effects of pioglitazone against type 2 diabetic cardiovascular and renal complications in obese mice

(2010) Masaya Fukuda et al.   JOURNAL OF HYPERTENSION

The Effect of Chronic Candesartan Therapy on the Metabolic Profile and Renal Tissue Cytokine Levels in the Obese Zucker Rat

(2010) Carolyn M. Ecelbarger et al.   MEDIATORS OF INFLAMMATION

Effects of xylazole alone and in combination with ketamine on the metabolic and neurohumoral responses in healthy dogs

(2010) Hu Changmin et al.   VETERINARY ANAESTHESIA AND ANALGESIA

AMP-activated protein kinase - a sensor of glycogen as well as AMP and ATP?

(2009) A. McBride et al.   Acta Physiologica

Peripherally Administered Angiotensin II AT1Receptor Antagonists Are Anti-stress Compoundsin Vivo

(2009) Jaroslav Pavel et al.   Annals of the New York Academy of Sciences

Systemic candesartan reduces brain angiotensin II via downregulation of brain renin–angiotensin system

(2009) Nicolas Pelisch et al.   HYPERTENSION RESEARCH

Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases

(2009) T Yamauchi et al.   INTERNATIONAL JOURNAL OF OBESITY

AMPK in the brain: its roles in energy balance and neuroprotection

(2009) Gabriele V. Ronnett et al.   JOURNAL OF NEUROCHEMISTRY

Neuroendocrine characterization and anorexigenic effects of telmisartan in diet- and glitazone-induced weight gain

(2009) Gregory Aubert et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Oxygen free radicals regulate energy metabolism via AMPK pathway following cerebral ischemia

(2009) Meng Li et al.   NEUROLOGICAL RESEARCH

Identification of Nitric Oxide as an Endogenous Activator of the AMP-activated Protein Kinase in Vascular Endothelial Cells

(2008) Junhua Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies

(2008) Hao Liu et al.   JOURNAL OF HYPERTENSION

Role of AMP-Activated Protein Kinase in the Control of Appetite

(2008) B. Kola   JOURNAL OF NEUROENDOCRINOLOGY

Effects of angiotensin II receptor blockade on glucose metabolism via AMP-activated protein kinase in insulin-resistant hypertensive rats

(2008) Daisuke Yoshida et al.   Journal of the American Society of Hypertension

Angiotensin II AT1receptor blockade selectively enhances brain AT2receptor expression, and abolishes the cold-restraint stress-induced increase in tyrosine hydroxylase mRNA in the locus coeruleus of spontaneously hypertensive rats

(2008) C. Bregonzio et al.   STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS

Chronic administration of an angiotensin II receptor antagonist resets the hypothalamic–pituitary–adrenal (HPA) axis and improves the affect of patients with diabetes mellitus type 2: Preliminary results

(2008) Maria G. Pavlatou et al.   STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS